Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy

por Friedman, Gregory K., Raborn, Joel, Kelly, Virginia M., Cassady, Kevin A., Markert, James M., Gillespie, G. Yancey
Publicado 2013

Duvelisib, an oral dual PI3K‐δ, γ inhibitor, shows clinical activity in indolent non‐Hodgkin lymphoma in a phase 1 study

por Flinn, Ian W., Patel, Manish, Oki, Yasuhiro, Horwitz, Steven, Foss, Francine F., Allen, Kerstin, Douglas, Mark, Stern, Howard, Sweeney, Jennifer, Kharidia, Jahnavi, Kelly, Patrick, Kelly, Virginia M., Kahl, Brad
Publicado 2018

Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002

por Ring, Eric K., Li, Rong, Moore, Blake P., Nan, Li, Kelly, Virginia M., Han, Xiaosi, Beierle, Elizabeth A., Markert, James M., Leavenworth, Jianmei W., Gillespie, G. Yancey, Friedman, Gregory K.
Publicado 2017

γ(1)34.5-Deleted HSV-1 Expressing Human Cytomegalovirus IRS1 Gene Kills Human Glioblastoma Cells as Efficiently as Wild-type HSV-1 in Normoxia or Hypoxia

por Friedman, Gregory K., Nan, Li, Haas, Marilyn C., Kelly, Virginia M., Moore, Blake P., Langford, Catherine P., Xu, Hui, Han, Xiaosi, Beierle, Elizabeth A., Markert, James M., Cassady, Kevin A., Gillespie, G. Yancey
Publicado 2014

Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression

por Friedman, Gregory K., Bernstock, Joshua D., Chen, Dongquan, Nan, Li, Moore, Blake P., Kelly, Virginia M., Youngblood, Samantha L., Langford, Catherine P., Han, Xiaosi, Ring, Eric K., Beierle, Elizabeth A., Gillespie, G. Yancey, Markert, James M.
Publicado 2018